Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 154

Sort by

Sort Order Select

Journal Articles

GABA gets blood on its hands

Antonio Morales-Hernández, Shannon McKinney-Freeman

Blood (2021) 137 (6): 723–724.

https://doi.org/10.1182/blood.2020008772

Published: 2021

Journal Articles

Does Venetoclax Cause Vitiligo?

Sujatha Baddam, MD, Jorge Diaz Castro, MD

Blood (2019) 134 (Supplement_1): 5139.

https://doi.org/10.1182/blood-2019-130854

Published: 2019

Journal Articles

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial

Blood (2019) 134 (Supplement_1): 1130.

https://doi.org/10.1182/blood-2019-124234

Published: 2019

Journal Articles

Sensitive Monitoring of BCR-ABL1 Kinase Domain Mutations By Next Generation Sequencing for Optimizing Clinical Decisions in Philadelphia-Positive Acute Lymphoblastic Leukemia in the Graaph-2014 Trial

Blood (2019) 134 (Supplement_1): 1295.

https://doi.org/10.1182/blood-2019-124029

Published: 2019

Journal Articles

Meds433, a New Dihydroorotate Dehydrogenase Inhibitor, Induces Apoptosis and Differentiation in Acute Myeloid Leukemia

Valentina Gaidano, MD, Paola Circosta, PhD, Alessandro Cignetti, MD PhD, Mohammad Houshmand, Nicoletta Vitale, PhD, Stefano Sainas, PhD, Agnese Pippione, PhD, Manuela Marraudino, PhD, Brigitta Bonaldo, MD, Marta Giorgis, PhD, Donatella Boschi, PhD, Marco Lucio Lolli, PhD, Giuseppe Saglio, MD

Blood (2019) 134 (Supplement_1): 3942.

https://doi.org/10.1182/blood-2019-128085

Published: 2019

Journal Articles

How to Collect the Minimum-Targeted CD3+ Cells for CAR-T Therapy- the Bern Approach

Katarzyna Aleksandra Jalowiec, Thomas Pabst, MD, Christoph Bocksrucker, Claudio Brunold, Barbara Jeker, Gabriela M Baerlocher, MD, Urban Novak, Ulrike Bacher, Michael Daskalakis, MD, Behrouz Mansouri, MD, Sacha S Zeerleder, MD PhD

Blood (2019) 134 (Supplement_1): 2457.

https://doi.org/10.1182/blood-2019-126534

Published: 2019

Journal Articles

Home Treatment of Bortezomib: A Preliminary Exploration of a New Treatment Mode in China

Congli Zhang, Xin-xin Cao, Dong-zhu Li, Jun Feng, MD, Lu Zhang, MD, Yan Zhang, Ming-hui Duan, MD, Miao Chen, MD, Chen Yang, Wei Wang, Dao-Bin Zhou, Jian Li, MD

Blood (2019) 134 (Supplement_1): 2127.

https://doi.org/10.1182/blood-2019-125505

Published: 2019

Journal Articles

An Educational Study Promoting the Delivery of TCD Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective

Baba PD Inusa, MD, Corrina Macmahon, MD, Laura Sainati, MD, Raffaella Colombatti, MD PhD, Maddalena Casale, MD PhD, Patrizia Rampazzo, MD, Silverio Perrotta, Soundrie Padayachee

Blood (2019) 134 (Supplement_1): 2172.

https://doi.org/10.1182/blood-2019-130390

Published: 2019

Journal Articles

A Simplified Method for Transduction and Expansion of T Cells for Clinical Application

Mariam Khalil, Aaron Foster, PhD, Christine Gagliardi, PhD

Blood (2018) 132 (Supplement 1): 4555.

https://doi.org/10.1182/blood-2018-99-119254

Published: 2018

Journal Articles

The Amount of Apoptosis Predicts Outcome in Ibrutinib-Treated Chronic Lymphocytic Leukemia (CLL)

Giovanni Del Poeta, MD, Massimiliano Postorino, MD, Federico Pozzo, PhD, Maria Ilaria Del Principe, MD, Enrico Santinelli, MD, Riccardo Bomben, PhD, Annalisa Biagi, MD, Francesco Buccisano, MD, Francesca Maria Rossi, PhD, Adriano Venditti, MD, Paolo de Fabritiis, MD, Maria Cantonetti, MD, Sergio Amadori, MD, Valter Gattei, MD, William Arcese

Blood (2018) 132 (Supplement 1): 4397.

https://doi.org/10.1182/blood-2018-99-113060

Published: 2018

Journal Articles

The HACE1-NRF2 Axis a Novel Target in Acute Myeloid Leukemia

Andoni Garitano-Trojaola, PhD, Eva Teufel, Nadine Rodhes, Jennifer Kreckel, Thorsten Stuehmer, Matteo Claudio Da Via', MD, Santiago Barrio Garcia, PhD, Torsten Haferlach, MD, Raoul Tibes, Harald Wajant, Andreas Rosenwald, Hermann Einsele, MD, K. Martin Kortüm, MD

Blood (2018) 132 (Supplement 1): 5132.

https://doi.org/10.1182/blood-2018-99-118270

Published: 2018

Journal Articles

A Clinical, Genomic and Proteomic Approach for the Characterization of Fanconi Anemia in Adolescent and Young Adult (AYA) Patients : A Single Center Study of 55 Patients from a National Bone Marrow Failure Referral Center

Blood (2018) 132 (Supplement 1): 2594.

https://doi.org/10.1182/blood-2018-99-114639

Published: 2018

Journal Articles

Standard Processing of Apheresis Products for HSCT Provides Significant Cost Savings over Automated Processing without Impact on Time or Product Quality

Lauren Bongo, MLS, Ravi Bhatia, MD, Lawrence S. Lamb, Jr., PhD

Blood (2018) 132 (Supplement 1): 5693.

https://doi.org/10.1182/blood-2018-99-119295

Published: 2018

Journal Articles

"in the Patients' Hands"- a Structured Survey of Patient Voices to Prioritise Research Questions in Rare Inherited Anaemias: The James Lind Alliance Priority Setting Partnership

Jenny Welch, Nick Meade, Dominic Messenger, Amy Hunter, Anupama Rao, MD, Subarna Chakravorty, Rachel Wearmouth, Anju Chalin, Kristina Staley, Sheela Upadhyaya, Irene Roberts, MD, Noemi Roy, MBBCH, MD

Blood (2018) 132 (Supplement 1): 5876.

https://doi.org/10.1182/blood-2018-99-115404

Published: 2018

Journal Articles

Our Hands, Our Health: Developing a Promising Group Healthcare Model for Pediatric to Adult Transition in a Sickle Cell Disease Clinic

Angela Rivers, MD, Ronisha Edwards, MSW, Divya Bhandar, Sharice Bradford, EdD, Brigid Packer, APRN, CNP, Robin Johnson, DNP, APN, CPNP, Nicole Rodos, CPNPAC, DNP, Susan Walsh, DNP, CPNP, Patil Crystal, PhD

Blood (2018) 132 (Supplement 1): 4713.

https://doi.org/10.1182/blood-2018-99-111848

Published: 2018

Journal Articles

Von Willebrand Factor Binding to Myosin Assists in Coagulation

Veronica H Flood, MD, Tricia L Slobodianuk, BS, Daniel A Keesler, BS, Hannah Lohmeier, Scot A Fahs, Robert R Montgomery, MD

Blood (2018) 132 (Supplement 1): 22.

https://doi.org/10.1182/blood-2018-99-113105

Published: 2018

Journal Articles

Results of Using Automated Clinimacs Prodigy for CD34 Selection from Mobilized Peripheral Blood Stem Cell Products

Caroline M Bateman, MDPhDFRCPath, Vicki Antonenas, BSc, Kenneth Yehson, Daochen Tong, Gurdip Hansra, Leighton Edward Clancy, PhD, Peter J. Shaw, MA,FRACP, Kenneth P. Micklethwaite, MBBS, PhD FRACP, FRCPA, David Gottlieb, MBBS, MD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 3201.

https://doi.org/10.1182/blood.V130.Suppl_1.3201.3201

Published: 2017

Journal Articles

PET-CT Does Not Impact on the Outcome of the Patients Affected By Multiple Myeloma after Autologous Transplantation: A Real Life Experience

Walter Bertolami, MD, Paola Anna Erba, Francesco Caracciolo, Edoardo Benedetti, MD, Enrico Orciuolo, Gabriele Buda, PhD MD, Riccardo Morganti, Sara Galimberti, PhD MD, Mario Petrini, PhD MD Prof

Blood (2017) 130 (Supplement 1): 5522.

https://doi.org/10.1182/blood.V130.Suppl_1.5522.5522

Published: 2017

Journal Articles

Excessive Early Death after Intensive Chemotherapy for Acute Myeloid Leukemia Occurs in Patients over 65 Years with High Co-Morbidity, and in Patients over 50 Years with High Co-Morbidity When Postponed Early Death Is Included

J Claire Sinigaglia, Liesbeth C de Wreede, PhD, Hendrik Veelken, MD PhD, Peter A. Von Dem Borne, MD PhD

Blood (2017) 130 (Supplement 1): 1316.

https://doi.org/10.1182/blood.V130.Suppl_1.1316.1316

Published: 2017

Journal Articles

Poor Agreement between Commercially Available Anti-Cardiolipin and Anti-β2glycoprotein I IgG and IgM Solid Phase Assays Hampers Uniformity in the Classification of Antiphospholipid Syndrome Patients

Walid Chayouâ, MSc, Hilde Kelchtermans, PhD, Gary Moore, MD, Jean-Christophe Gris, MD PhD, Jacek Musial, MD PhD, Denis Wahl, MD PhD, Stéphane Zuily, MDPhD, Armando Tripodi, PhD, Pierre Fontana, MD PhD, Jasper A. Remijn, PhD, Bas De Laat, MD PhD, Katrien Devreese, MD PhD

Blood (2017) 130 (Supplement 1): 1059.

https://doi.org/10.1182/blood.V130.Suppl_1.1059.1059

Published: 2017

NARROW

GABA gets blood on its hands

Does Venetoclax Cause Vitiligo?

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial

Sensitive Monitoring of BCR-ABL1 Kinase Domain Mutations By Next Generation Sequencing for Optimizing Clinical Decisions in Philadelphia-Positive Acute Lymphoblastic Leukemia in the Graaph-2014 Trial

Meds433, a New Dihydroorotate Dehydrogenase Inhibitor, Induces Apoptosis and Differentiation in Acute Myeloid Leukemia

How to Collect the Minimum-Targeted CD3+ Cells for CAR-T Therapy- the Bern Approach

Home Treatment of Bortezomib: A Preliminary Exploration of a New Treatment Mode in China

An Educational Study Promoting the Delivery of TCD Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective

A Simplified Method for Transduction and Expansion of T Cells for Clinical Application

The Amount of Apoptosis Predicts Outcome in Ibrutinib-Treated Chronic Lymphocytic Leukemia (CLL)

The HACE1-NRF2 Axis a Novel Target in Acute Myeloid Leukemia

A Clinical, Genomic and Proteomic Approach for the Characterization of Fanconi Anemia in Adolescent and Young Adult (AYA) Patients : A Single Center Study of 55 Patients from a National Bone Marrow Failure Referral Center

Standard Processing of Apheresis Products for HSCT Provides Significant Cost Savings over Automated Processing without Impact on Time or Product Quality

"in the Patients' Hands"- a Structured Survey of Patient Voices to Prioritise Research Questions in Rare Inherited Anaemias: The James Lind Alliance Priority Setting Partnership

Our Hands, Our Health: Developing a Promising Group Healthcare Model for Pediatric to Adult Transition in a Sickle Cell Disease Clinic

Von Willebrand Factor Binding to Myosin Assists in Coagulation

Results of Using Automated Clinimacs Prodigy for CD34 Selection from Mobilized Peripheral Blood Stem Cell Products

PET-CT Does Not Impact on the Outcome of the Patients Affected By Multiple Myeloma after Autologous Transplantation: A Real Life Experience

Excessive Early Death after Intensive Chemotherapy for Acute Myeloid Leukemia Occurs in Patients over 65 Years with High Co-Morbidity, and in Patients over 50 Years with High Co-Morbidity When Postponed Early Death Is Included

Poor Agreement between Commercially Available Anti-Cardiolipin and Anti-β2glycoprotein I IgG and IgM Solid Phase Assays Hampers Uniformity in the Classification of Antiphospholipid Syndrome Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only